---
title: "Sinus Surgery"
order: 2
category: "Otolaryngology"
---

# Functional Endoscopic Sinus Surgery (FESS)

## Overview

Functional endoscopic sinus surgery (FESS) represents the cornerstone of surgical treatment for chronic rhinosinusitis and sinonasal pathology. This minimally invasive approach uses nasal endoscopes to visualize and operate within the paranasal sinuses through the natural ostia. FESS aims to restore normal sinus ventilation and drainage while preserving normal mucosa and anatomic structures. The advent of endoscopic techniques has revolutionized sinus surgery, reducing morbidity and improving outcomes compared to traditional external approaches.

## Anatomy and Physiology

### Paranasal Sinuses

**Maxillary Sinuses**:
- Largest paranasal sinuses
- Pyramidal shape, volume 15-20mL
- **Ostium**: Drains into middle meatus via infundibulum
- **Relations**: Orbit (superiorly), oral cavity (inferiorly), nasal cavity (medially), pterygopalatine fossa (posteriorly)
- **Innervation**: Infraorbital and superior alveolar nerves (V2)
- **Blood supply**: Internal maxillary artery branches

**Ethmoid Sinuses**:
- 3-18 air cells on each side
- **Anterior ethmoid cells**: Drain into middle meatus
- **Posterior ethmoid cells**: Drain into superior meatus
- **Key landmarks**:
  - **Basal lamella (ground lamella)**: Middle turbinate attachment, divides anterior and posterior ethmoid
  - **Lamina papyracea**: Thin bone separating ethmoid from orbit
  - **Skull base**: Fovea ethmoidalis and cribriform plate (CSF leak risk)
- **Blood supply**: Anterior and posterior ethmoid arteries

**Frontal Sinuses**:
- Most variable sinus anatomy
- Drainage pathway: Frontal recess → middle meatus
- **Relations**: Orbit (laterally/inferiorly), anterior cranial fossa (posteriorly)
- **Frontal recess cells**: Agger nasi, supraorbital ethmoid, frontal bullar, interfrontal sinus septal cell

**Sphenoid Sinuses**:
- Posterior to ethmoid, volume 5-7mL
- **Ostium**: Sphenoethmoidal recess
- **Critical relations**:
  - **Lateral wall**: Carotid artery, optic nerve (dehiscent in 4-8%)
  - **Superior**: Pituitary gland, optic chiasm
  - **Posterior**: Clivus
- **Onodi cell**: Posterior ethmoid cell pneumatizes lateral/superior to sphenoid (optic nerve risk)

### Ostiomeatal Complex (OMC)

**Definition**: Functional unit of anterior ethmoid drainage
- **Components**: Middle meatus, ethmoid infundibulum, hiatus semilunaris, maxillary ostium, frontal recess
- **Function**: Common drainage pathway for maxillary, frontal, and anterior ethmoid sinuses
- **Obstruction**: OMC blockage leads to stagnation, infection, chronic rhinosinusitis

### Mucociliary Clearance

- Normal sinuses lined with respiratory epithelium (ciliated pseudostratified columnar)
- **Mucus**: Produced by goblet cells, forms blanket over epithelium
- **Cilia**: Beat in coordinated fashion (10-20 Hz), transport mucus toward ostia
- **Direction**: Maxillary sinus mucus flows superiorly toward ostium (against gravity)
- **Dysfunction**: Impaired clearance in chronic rhinosinusitis, cystic fibrosis, primary ciliary dyskinesia

## Chronic Rhinosinusitis

### Definition and Epidemiology

**Diagnostic Criteria** (need both):
1. **≥12 weeks of symptoms**: Nasal obstruction, nasal discharge (anterior/posterior drip), facial pain/pressure, hyposmia
2. **Objective evidence**: Endoscopy (mucopurulence, polyps, edema) or CT (mucosal thickening, obstruction)

**Prevalence**: 10-12% of population
**Impact**: Quality of life impairment comparable to chronic diseases (heart failure, COPD)

### Classification

**Without Nasal Polyps (CRSsNP)**:
- 60-65% of CRS cases
- Associated with bacterial biofilms, Staphylococcus aureus
- Th1-mediated inflammation
- Better response to surgery typically

**With Nasal Polyps (CRSwNP)**:
- 35-40% of CRS cases
- Inflammatory polyps (not neoplastic) from middle meatus
- Type 2 inflammation (eosinophilic): IL-4, IL-5, IL-13
- Associated with asthma (50%), aspirin sensitivity (10%), cystic fibrosis
- Higher recurrence rate after surgery

### Pathophysiology

**Multifactorial**:
1. **Obstruction**: OMC blockage → impaired drainage → stasis → infection
2. **Infection**: Bacterial (S. aureus, polymicrobial), fungal (allergic fungal sinusitis)
3. **Inflammation**: Dysregulated immune response, biofilms
4. **Mucociliary dysfunction**: Impaired clearance

**Unified Airway Concept**: CRS often coexists with asthma (shared pathophysiology)

### Medical Management

**First-Line Treatment** (EPOS guidelines):
- **Saline irrigation**: High-volume (240mL/day), reduces symptoms, removes debris
- **Intranasal corticosteroids**: Mometasone, fluticasone (reduce inflammation)
- **Antibiotics** (if purulent discharge): 3-4 weeks (culture-directed if possible)
  - First-line: Amoxicillin-clavulanate
  - Alternatives: Doxycycline, levofloxacin
- **Oral corticosteroids**: Short course (1-3 weeks) for severe exacerbations, polyps

**Adjunctive**:
- Leukotriene inhibitors (if asthma)
- Biologics for severe CRSwNP: Dupilumab (anti-IL-4/IL-13), omalizumab (anti-IgE)

**Surgery Indications**: Failure of maximum medical therapy (3-6 months), complications

## Indications for Surgery

### Primary Indications

**Chronic Rhinosinusitis**:
- Failed maximum medical therapy (intranasal steroids, antibiotics, saline irrigation for ≥3 months)
- Recurrent acute rhinosinusitis (≥4 episodes per year)
- Persistent symptoms affecting quality of life

**Nasal Polyposis**:
- Obstructive polyps causing nasal obstruction, hyposmia
- Failed medical management (steroids)

**Fungal Sinusitis**:
- **Allergic fungal sinusitis**: Thick allergic mucin, fungal hyphae, eosinophilia
- **Fungal ball**: Noninvasive mass (usually maxillary sinus)

**Odontogenic Sinusitis**:
- Dental infection extending into maxillary sinus
- Often requires dental treatment + FESS

### Urgent/Emergent Indications

**Acute Complicated Rhinosinusitis**:
- **Orbital complications**: Preseptal/postseptal cellulitis, abscess, vision loss
- **Intracranial complications**: Meningitis, epidural/subdural abscess, cavernous sinus thrombosis
- Requires IV antibiotics + urgent drainage if abscess

**Invasive Fungal Sinusitis**:
- Acute fulminant (immunocompromised, diabetic ketoacidosis)
- **Mucormycosis**: Aggressive, tissue invasion, vascular thrombosis
- Requires urgent debridement + antifungals (amphotericin)

### Other Indications

- **Cerebrospinal fluid (CSF) leak**: Repair of traumatic or spontaneous leak
- **Sinonasal tumors**: Biopsy, resection (benign or selected malignant)
- **Dacryocystorhinostomy**: Restore lacrimal drainage
- **Pituitary surgery**: Transsphenoidal approach to sella
- **Optic nerve decompression**: Traumatic optic neuropathy, fibrous dysplasia

## Preoperative Assessment

### Clinical Evaluation

**History**:
- Symptom duration and severity (VAS scale, SNOT-22 questionnaire)
- Prior medical treatments (steroids, antibiotics, duration)
- Prior surgeries
- Comorbidities: Asthma, aspirin sensitivity, cystic fibrosis, immunodeficiency
- Medications: Anticoagulants, steroids, biologics

**Physical Examination**:
- **Anterior rhinoscopy**: Septal deviation, turbinate hypertrophy, discharge
- **Nasal endoscopy**: Document polyps, mucopurulent discharge, inflammation, masses
- **Cranial nerves**: Especially if concern for complications (V1/V2, VI for cavernous sinus)

### Imaging

**CT Sinus** (gold standard):
- **Protocol**: Non-contrast, coronal and axial views, 1mm cuts
- **Timing**: After medical therapy (eliminate reversible mucosal edema)
- **Assess**:
  - Extent of disease (Lund-Mackay score: 0-24)
  - Anatomic variants (Keros classification, Onodi cell, haller cell, concha bullosa, septal deviation)
  - Surgical planning (identify landmarks, dehiscences)
- **Lund-Mackay Score**: Each sinus 0-2 (0=normal, 1=partial opacification, 2=complete), OMC 0-2

**Image-Guided Surgery**:
- CT-based navigation system
- **Indications**: Revision surgery, complex anatomy, skull base lesions, frontal sinus surgery, CSF leak
- Real-time localization, reduces complications

**MRI**:
- Better tissue characterization
- **Indications**: Tumor evaluation, fungal vs. inflammatory disease, CSF leak, intracranial extension
- **T2**: Fluid bright (retention cysts, mucoceles), fungal ball dark (low signal)

### Laboratory

- Usually not required for routine FESS
- **If indicated**: CBC (eosinophilia suggests allergic fungal sinusitis), IgE, aspergillus serology
- **Cystic fibrosis**: Sweat chloride, genetic testing (if recurrent polyps in children)

### Consent

**Risks**:
- **Common**: Bleeding, infection, adhesions, recurrence, need for revision surgery
- **Serious**: CSF leak (0.5%), orbital injury (0.5-3%), vision loss (rare, 0.01-0.04%), meningitis, brain abscess
- **Nasal**: Altered smell/taste, septal perforation, nasal crusting

## Surgical Technique

### Preparation

**Decongestion**:
- Topical vasoconstrictors (oxymetazoline, cocaine 4%, epinephrine-soaked pledgets)
- Reduce mucosal bleeding, improve visualization

**Injection**:
- 1% lidocaine with 1:100,000 epinephrine
- Inject uncinate process, middle turbinate, lateral nasal wall (vasoconstriction)

**Anesthesia**:
- General anesthesia (most cases)
- Controlled hypotension (MAP 60-70mmHg) reduces bleeding
- Total intravenous anesthesia (TIVA) may reduce bleeding vs. volatile agents

### Basic FESS Principles

**Goal**: Restore sinus ventilation and drainage, preserve normal mucosa
- Remove disease (polyps, diseased mucosa)
- Open obstructed ostia
- Create adequate drainage pathways
- Avoid damage to healthy tissue, skull base, orbit

**Stepwise Approach** (posterior to anterior, inferior to superior):
1. **Maxillary antrostomy**
2. **Anterior ethmoidectomy**
3. **Posterior ethmoidectomy**
4. **Sphenoidotomy** (if indicated)
5. **Frontal sinusotomy** (if indicated)

### Maxillary Antrostomy

**Landmarks**:
- Uncinate process (medial wall of infundibulum)
- Fontanelles (membranous areas medial to maxillary sinus)
- Natural maxillary ostium (posterior fontanelle)

**Technique**:
1. **Uncinectomy**: Incise uncinate anteriorly (backbiter, sickle knife), remove entirely
2. **Identify natural ostium**: Usually posterior-superior to inferior turbinate insertion
3. **Enlarge ostium**: Remove posterior fontanelle (backbiter, through-cutting forceps)
4. **Final opening**: 1-2cm diameter, avoid damage to nasolacrimal duct (anterior), inferior turbinate

**Pitfalls**:
- **Nasolacrimal duct injury**: Anterosuperior (epiphora postoperatively)
- **Recirculation**: Creating accessory ostium instead of enlarging natural ostium

### Anterior Ethmoidectomy

**Landmarks**:
- Basal lamella (middle turbinate ground lamella)
- Lamina papyracea (lateral wall)
- Skull base (superior)

**Technique**:
1. **Remove ethmoid bulla**: Large anterior ethmoid cell, posterior to frontal recess
2. **Open ethmoid cells**: Systematic removal anterior to basal lamella
3. **Identify lamina papyracea**: Thin bone, orbit laterally (AVOID perforation)
4. **Identify skull base**: Ethmoid roof, often slopes (Keros classification)
5. **Preserve mucosa**: When possible, remove disease but preserve normal mucosa

**Keros Classification** (depth of olfactory fossa):
- Type I: 1-3mm (shallow, CSF leak risk lower)
- Type II: 4-7mm (most common)
- Type III: 8-16mm (deep, CSF leak risk higher)

### Posterior Ethmoidectomy

**Landmarks**:
- Basal lamella (divide to enter posterior ethmoid)
- Skull base
- Lamina papyracea
- Anterior sphenoid wall

**Technique**:
1. **Perforate basal lamella**: Enter posterior ethmoid compartment
2. **Remove posterior cells**: Systematic removal to sphenoid face
3. **Preserve superior turbinate**: Olfaction
4. **Identify sphenoid**: Posterior boundary

**Risks**: Skull base injury (posterior ethmoid roof often lower than anterior), optic nerve (Onodi cell)

### Sphenoidotomy

**Landmarks**:
- Sphenoid ostium: Superomedial to superior turbinate insertion (~7cm from nasal sill)
- Anterior sphenoid wall

**Technique**:
1. **Locate ostium**: Superior meatus, 1.5cm superior to choana
2. **Enlarge ostium**: Kerrison punch, through-cutting forceps
3. **Remove anterior wall**: Preserve medial and lateral walls (carotid, optic nerve)
4. **Inspect interior**: Remove disease (polyps, fungal ball), avoid lateral wall

**Critical Anatomy**:
- **Carotid artery**: Lateral wall (may be dehiscent)
- **Optic nerve**: Superolateral (may be dehiscent)
- **Pituitary**: Superior (transsphenoidal surgery access)

**Onodi Cell**: Posterior ethmoid cell pneumatizes lateral to sphenoid
- Optic nerve courses through Onodi lateral wall (injury risk if mistaken for sphenoid)

### Frontal Sinusotomy

**Most challenging** due to complex anatomy, small drainage pathway

**Landmarks**:
- Agger nasi cell (anteriormost ethmoid cell, anterior to frontal recess)
- Frontal recess (drainage pathway, 1-2mm diameter)
- **"Axilla" of middle turbinate**: Insertion on lateral nasal wall (marks posterior boundary)

**Draf Classification**:
- **Draf I**: Remove agger nasi, enlarge natural ostium (conservative)
- **Draf IIA**: Type I + dissection to frontal sinus floor, medial to lamina
- **Draf IIB**: Type IIA + removal of frontal sinus floor anterior to lamina
- **Draf III (modified Lothrop)**: Bilateral Draf IIB + remove superior nasal septum, create common frontal neo-ostium (revision, extensive disease)

**Technique** (Draf IIA):
1. **Remove agger nasi**: First step, exposes frontal recess
2. **Identify frontal ostium**: Superiorly, follow "frontal sinus pathway"
3. **Enlarge opening**: Remove cells obstructing frontal recess
4. **Preserve mucosa**: Minimize damage to frontal recess mucosa (stenosis risk)

**Pitfalls**: Scarring/stenosis of frontal recess (narrow funnel), recurrent disease

### Balloon Sinuplasty

**Minimally invasive technique**:
- Catheter with balloon inserted into sinus ostium
- Inflate balloon (10-12 atm) to dilate ostium
- Deflate and remove balloon

**Advantages**: Preserve mucosa, less bleeding, faster recovery
**Limitations**: Cannot remove polyps or diseased tissue
**Indications**: Recurrent acute rhinosinusitis, limited chronic disease, frontal/maxillary sinus dilation

### Image-Guided Surgery

**Components**: Preoperative CT, infrared camera, instruments with tracking sensors, real-time display

**Benefits**:
- Real-time localization
- Confirm anatomy (especially if distorted)
- Safer in complex cases

**Limitations**: Not substitute for anatomic knowledge, registration error (1-3mm), instrument deflection

**Indications**: Revision surgery, CSF leak repair, frontal sinus surgery, skull base tumors, complex anatomy

## Postoperative Management

### Immediate Postoperative

**Recovery**:
- Same-day discharge typical
- Monitor for bleeding, vision changes

**Nasal Care**:
- **Nasal saline irrigation**: Start POD 1-2 (high-volume, 2-3x daily)
  - Removes crusts, blood clots, promotes healing
  - Continue for 3-6 months
- **Avoid nose blowing**: First 1-2 weeks (prevent bleeding, CSF leak if skull base entry)
- **Humidification**: Reduce crusting

**Medications**:
- **Intranasal corticosteroids**: Resume after initial healing (1-2 weeks), long-term maintenance
- **Antibiotics**: 1-2 weeks (if extensive disease, purulence)
- **Pain**: Acetaminophen, avoid NSAIDs initially (bleeding risk)
- **Oral steroids**: Taper if used for polyposis

**Activity**:
- Avoid strenuous activity for 2 weeks (bleeding risk)
- Elevate head of bed

### Debridement

**Critical for success**: Remove crusts, clots, adhesions

**Schedule**:
- **First debridement**: POD 5-7 (remove clots, inspect)
- **Subsequent**: Weekly until healed (typically 4-6 weeks)

**Technique**: Endoscopic, suction, forceps to remove debris (may need topical anesthetic)

**Goal**: Prevent adhesions (middle turbinate to lateral wall), promote healing

### Long-Term

**Follow-Up**:
- Regular endoscopy (every 3-6 months initially)
- Monitor for recurrence, polyps

**Maintenance**:
- **Saline irrigation**: Indefinite (especially CRSwNP)
- **Intranasal steroids**: Long-term (reduce recurrence)
- **Biologics**: Dupilumab for severe CRSwNP with asthma (reduces polyp recurrence)

**Surveillance**: Symptom assessment (SNOT-22), endoscopic examination

## Complications

### Intraoperative

**Bleeding**:
- Common, usually controlled with vasoconstriction, cautery
- **Sphenopalatine artery**: Posterior lateral nasal wall (ligation or cautery)
- **Anterior/posterior ethmoid artery**: Skull base, can retract into orbit (cautery, clips)
- Severe bleeding rare but may require packing, embolization

**Orbital Injury** (0.5-3%):
- **Periorbital fat**: Yellow tissue herniating through lamina papyracea
- **Extraocular muscle injury**: Medial rectus most at risk
- **Optic nerve injury**: Rare, devastating (Onodi cell, sphenoid surgery)
- **Management**:
  - Recognize immediately (fat herniation, vision changes)
  - Stop surgery, ophthalmology consult
  - High-dose IV corticosteroids if optic nerve concern
  - Orbital hematoma: Emergent lateral canthotomy/cantholysis if vision threatened

**CSF Leak** (0.5%):
- **Risk factors**: Revision surgery, skull base pathology, extensive disease
- **Recognition**: Clear fluid, "reservoir sign" (fluid collects with head down), beta-2 transferrin (confirm CSF)
- **Management**:
  - Small leaks: Conservative (bed rest, acetazolamide to reduce CSF production)
  - Larger leaks: Endoscopic repair (fat, fascia, mucosal graft with tissue glue/overlay)
  - Lumbar drain if extensive

**Carotid Injury**:
- Rare but catastrophic
- **Risk**: Sphenoid surgery, dehiscent carotid
- **Management**: Pack immediately, vascular surgery, endovascular repair

### Postoperative

**Early**:
- **Bleeding**: Usually minor, resolves with decongestants, head elevation
  - Severe: May need packing, cautery, rarely embolization
- **Infection**: Sinusitis, orbital cellulitis (rare)
- **Adhesions/synechiae**: Middle turbinate to lateral wall (prevent with debridement, sometimes spacers)

**Late**:
- **Recurrence of disease**: Most common long-term issue
  - **CRSwNP**: 20-40% recurrence (higher than CRSsNP)
  - Manage with continued medical therapy, biologics, revision surgery if needed
- **Frontal sinus stenosis**: Scarring of frontal recess (difficult to treat)
- **Empty nose syndrome**: Rare, excessive turbinate resection (feeling of nasal obstruction despite patent airway)
- **Anosmia**: Loss of smell (rare if preservation of olfactory mucosa)

**Neurological**:
- **CSF leak**: Can present delayed (rhinorrhea, meningitis risk)
- **Meningitis**: Rare (CSF leak, intracranial infection)

## Outcomes

### Success Rates

**Symptom improvement**: 80-90% of patients report improvement
**Objective findings**: Endoscopic improvement in most cases
**Revision surgery**: 10-20% require revision within 5 years (higher for CRSwNP, frontal sinus disease)

### Prognostic Factors

**Favorable**:
- CRSsNP (better than CRSwNP)
- Localized disease
- Absence of asthma
- Good medical compliance postoperatively

**Unfavorable**:
- CRSwNP with asthma
- Aspirin-exacerbated respiratory disease
- Cystic fibrosis
- Extensive disease (high Lund-Mackay score)
- Revision surgery
- Poor compliance with postoperative care

### Quality of Life

**SNOT-22**: Sinonasal Outcome Test (validated questionnaire)
- Significant improvement in most patients (mean decrease 20-30 points)

**Cost-effectiveness**: FESS cost-effective for patients failing medical therapy

## Special Considerations

### Allergic Fungal Rhinosinusitis

**Characteristics**:
- Type 1 hypersensitivity to fungal antigens
- Thick, tenacious "allergic mucin" (peanut butter consistency)
- Eosinophilia (blood and tissue)
- Nasal polyposis, bone erosion/remodeling

**Diagnosis**: Fungal hyphae on histology, elevated IgE, positive fungal culture

**Management**:
- **Surgery**: Complete removal of allergic mucin, polyps (may require multiple procedures)
- **Medical**: Systemic corticosteroids, topical steroids, immunotherapy, antifungals (controversial)
- **Follow-up**: Close surveillance (high recurrence)

### Odontogenic Sinusitis

**Cause**: Dental infection (periapical abscess, periodontal disease, dental procedures) extending into maxillary sinus

**Clinical**: Unilateral maxillary sinusitis, foul-smelling discharge, often resistant to typical antibiotics

**Diagnosis**: Dental exam, CT (dental roots in sinus, bony defect)

**Management**:
- **Dental treatment**: Extract/treat affected tooth
- **FESS**: Maxillary antrostomy, remove debris
- **Antibiotics**: Anaerobic coverage (amoxicillin-clavulanate, clindamycin)

### Pediatric FESS

**Indications**: Similar to adults but more conservative (anatomy still developing)
- Complications of acute sinusitis (orbital, intracranial)
- Failed medical therapy (>3 months)
- Recurrent acute rhinosinusitis

**Differences**:
- Smaller anatomy, closer structures
- Adenoid hypertrophy often contributes (adenoidectomy may help)
- Less extensive disease typically

**Complications**: Similar risks but lower overall

## Advances and Future Directions

**Biologics**:
- Dupilumab (anti-IL-4/IL-13 receptor): FDA-approved for CRSwNP
- Reduces polyp size, improves symptoms, may reduce need for surgery
- Omalizumab (anti-IgE), mepolizumab (anti-IL-5): Also effective

**Drug-Eluting Stents**:
- Steroid-eluting implants placed in sinuses (mometasone)
- Reduce inflammation, adhesions postoperatively
- FDA-approved for frontal and ethmoid

**Extended Endoscopic Approaches**:
- Endoscopic skull base surgery (pituitary, clival lesions)
- Endoscopic orbital decompression (Graves' ophthalmopathy)
- Endoscopic optic nerve decompression

**Office-Based Procedures**:
- Balloon sinuplasty, limited polypectomy under local anesthesia
- Reduces cost, faster recovery

## Key Points

- FESS is gold standard surgical treatment for chronic rhinosinusitis failing medical therapy
- Surgery aims to restore sinus drainage while preserving normal mucosa and anatomy
- Detailed anatomic knowledge essential: lamina papyracea (orbital injury), skull base (CSF leak), carotid/optic nerve
- CT sinus mandatory preoperatively for surgical planning and identifying anatomic variants
- Basic FESS includes maxillary antrostomy, anterior/posterior ethmoidectomy; add sphenoidotomy and frontal sinusotomy as needed
- Image-guided surgery beneficial for revision cases, complex anatomy, skull base work
- Postoperative care critical: saline irrigation, debridement, topical steroids prevent recurrence
- Major complications rare but serious: orbital injury (0.5-3%), CSF leak (0.5%), vision loss (0.01-0.04%)
- CRSwNP has higher recurrence than CRSsNP; biologics emerging as important adjunct
- Success rate 80-90% symptom improvement, but 10-20% require revision surgery within 5 years
- Frontal sinus surgery technically challenging with higher stenosis risk
- Allergic fungal sinusitis requires complete mucin removal and long-term medical management

## References

1. Orlandi RR, et al. International Consensus Statement on Allergy and Rhinology: Rhinosinusitis. Int Forum Allergy Rhinol. 2016;6(Suppl 1):S22-S209
2. Fokkens WJ, et al. European Position Paper on Rhinosinusitis and Nasal Polyps 2020. Rhinology. 2020;58(Suppl S29):1-464
3. Rosenfeld RM, et al. Clinical Practice Guideline (Update): Adult Sinusitis. Otolaryngol Head Neck Surg. 2015;152(2 Suppl):S1-S39
4. Kennedy DW, et al. Functional Endoscopic Sinus Surgery: Concepts, Surgical Indications, and Instrumentation. In: Cummings Otolaryngology (2020)
5. Weber RK, Hosemann W. Comprehensive review on endonasal endoscopic sinus surgery. GMS Curr Top Otorhinolaryngol Head Neck Surg. 2015;14:Doc08
